Dynavax Technologies Corp.
DVAX
Market Cap$1.39B
Close$
$2.56
73.6% downside
Current Fair Value
73.6% downsideOvervalued by 73.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.39 Billion |
|---|---|
| Enterprise Value | $1.55 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.21 |
| Beta | 1.26 |
| Outstanding Shares | 127,952,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 53.08 |
|---|---|
| PEG | 229.85 |
| Price to Sales | 4.85 |
| Price to Book Ratio | 2.42 |
| Enterprise Value to Revenue | 5.95 |
| Enterprise Value to EBIT | 500.47 |
| Enterprise Value to Net Income | 75 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.43 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Dynavax Technologies Corp.
CEO: Ryan Spencer